Melanoma Evidence & Self-Care · education / decision-support

← Evidence library

BIB_323

Ribas A et al. (UCLA + SWOG cooperative group). SWOG S1512: Phase 2 anti-PD-1 in unresectable desmoplastic melanoma. Nat Med November 2025. Key number: 70% RR. Confirms desmoplastic as the most ICI-sensitive cutaneous subtype. [Tasks: 01, 18, 19b] Tier: 1 (Nature Medicine phase 2) Grade: A Retrieved: 2026-05-15

Evidence grade
A
Tier
1 (Nature Medicine phase 2)
Cited by tasks
01, 18, 19b
Identifiers

Full extracted findings & patient-implication analysis: bibliography/BIB_323/findings.md (research corpus). This page is a short context summary — not individualised medical advice.